Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer
- 315 Downloads
The survival of patients with advanced gastric cancer after D2 dissection is still poor. Asian surgeons have proposed a more radical lymph node dissection, designated as D4 dissection, where paraaortic lymph nodes are removed in combination with D2 dissection. To evaluate the survival benefit of D4 dissection, a multi-institutional randomized trial of D2 vs D4 gastrectomy was conducted.
Patients enrolled in the study had potentially curable gastric adenocarcinoma at an advanced stage. Patients were randomized to undergo either D2 or D4 gastrectomy.
Two hundred and ninety-three patients were registered and 269 patients were eligible; 135 patients were allocated to the D2 group and 134 to the D4 group. Five-year survival was 52.6% after D2 surgery and 55.0% after D4 gastrectomy. There was no significant difference in survival between the D2 and D4 groups (χ2 = 0.064; P = 0.801). Hospital deaths occurred in 1 patients (0.7%) in the D2 group and 5 in the D4 group D4 gastrectomy is a more risky surgery than D2 dissection. Seven patients (5.2%) in the D2 and 15 (11.2%) in the D4 group died of causes other than gastric cancer recurrence. Sixty-three patients (46.7%) in the D2 group and 52 (38.8%) in the D4 group had disease recurrence.
Prophylactic D4 dissection is not recommended for patients with potentially curable advanced gastric cancer.
Key wordsGastric cancer Gastrectomy Lymphadenectomy Paraaortic lymph nodes D2 dissection D4 dissection
Unable to display preview. Download preview PDF.
- 2.Japanese Gastric Cancer Association (eds) (2004) Guidelines for the treatment of gastric cancer. Kanehara Shuppan, TokyoGoogle Scholar
- 11.Yonemura Y, Wu CC, Fukushima N, et al. and the East Asia Surgical Oncology Group (2006) Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 53:389–394PubMedGoogle Scholar
- 12.Japanese Research Society for Gastric Cancer (1995) The general rules for the gastric cancer study in surgery and pathology. First English edition., Kanehara Shuppan, TokyoGoogle Scholar
- 13.Sobin LH, Wittekind Ch (eds) (2002) UICC International Union Against Cancer TNM classification of malignant tumours. Sixth edition. John Wiley & Sons, pp 65–67Google Scholar
- 18.Kunisaki C, Shimada H, Yamaoka H, et al. (1994) Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepatogastroenterology 46:2635–2642Google Scholar
- 19.Yonemura Y (1996) Extended radical gastrectomy: its indication and results. In: Yonemura Y (ed) Contemporary approaches toward cure of gastric cancer. Maeda Shoten, Kanazawa, pp 56–60Google Scholar
- 20.Yonemura Y (1996) Lymphatic systems of the stomach and the patterns of lymph node metastases. In: Yonemura Y (ed) Contemporary approaches toward cure of gastric cancer. Maeda Shoten, Kanazawa, pp 3–14Google Scholar
- 23.Sasako M, Sano T, Yamamoto S, et al., Japan Clinical Oncology Group. Randomized phases III trial of standard D2 versus D2+paraaortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG 9501. Abstract of 2006 ASCO Annual Meeting, www.asco.orgGoogle Scholar